These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


554 related items for PubMed ID: 7791100

  • 1. Does [3H]2-methoxy-idazoxan (RX 821002) detect more alpha-2-adrenoceptor agonist high-affinity sites than [3H]rauwolscine? A comparison of nine tissues and cell lines.
    Erdbrügger W, Raulf M, Otto T, Michel MC.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1287-94. PubMed ID: 7791100
    [Abstract] [Full Text] [Related]

  • 2. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
    Michel MC, Brodde OE, Schnepel B, Behrendt J, Tschada R, Motulsky HJ, Insel PA.
    Mol Pharmacol; 1989 Mar; 35(3):324-30. PubMed ID: 2564631
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL, Leslie FM.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1092-8. PubMed ID: 2885406
    [Abstract] [Full Text] [Related]

  • 4. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    Renouard A, Widdowson PS, Millan MJ.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D, Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [Abstract] [Full Text] [Related]

  • 6. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
    O'Rourke MF, Blaxall HS, Iversen LJ, Bylund DB.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1362-7. PubMed ID: 7908054
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anatomical evidence for alpha-2 adrenoceptor heterogeneity: differential autoradiographic distributions of [3H]rauwolscine and [3H]idazoxan in rat brain.
    Boyajian CL, Loughlin SE, Leslie FM.
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1079-91. PubMed ID: 3037066
    [Abstract] [Full Text] [Related]

  • 11. Binding of [3H]idazoxan and of its methoxy derivative [3H] RX821002 in human fat cells: [3H]idazoxan but not [3H] RX821002 labels additional non-alpha 2-adrenergic binding sites.
    Langin D, Paris H, Lafontan M.
    Mol Pharmacol; 1990 Jun; 37(6):876-85. PubMed ID: 1972775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High affinity binding of 3H rauwolscine and 3H RX781094 to alpha 2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes.
    Convents A, Convents D, De Backer JP, De Keyser J, Vauquelin G.
    Biochem Pharmacol; 1989 Feb 01; 38(3):455-63. PubMed ID: 2563652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1993 Mar 01; 264(3):1187-97. PubMed ID: 8095548
    [Abstract] [Full Text] [Related]

  • 18. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1993 Jul 01; 109(3):831-7. PubMed ID: 8102937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.